郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.

期刊：Bioorganic & medicinal chemistry发表年份：2014作者：Antonella Brizzi; Francesca Aiello; Pietro Marini; Maria Grazia Cascio; Federico Corelli; Vittorio Brizzi; Luciano De Petrocellis; Alessia Ligresti; Livio Luongo; Stefania Lamponi; Sabatino Maione; Roger G Pertwee; Vincenzo Di Marzo
阅读更多 →

药效评价Structure-activity relationship study around guanabenz identifies two derivatives retaining antiprion activity but having lost α2-adrenergic receptor agonistic activity.

期刊：ACS chemical neuroscience发表年份：2014作者：Phu Hai Nguyen; Hassan Hammoud; Sophie Halliez; Yanhong Pang; Justine Evrard; Martine Schmitt; Nassima Oumata; Jean-Jacques Bourguignon; Suparna Sanyal; Vincent Beringue; Marc Blondel; Frédéric Bihel; Cécile Voisset
阅读更多 →

药效评价Molecular determinants of agonist selectivity in glutamate-gated chloride channels which likely explain the agonist selectivity of the vertebrate glycine and GABAA-ρ receptors.

期刊：PloS one发表年份：2014作者：Thomas Blarre; Hugues-Olivier Bertrand; Francine C Acher; JacSue Kehoe
阅读更多 →

药效评价Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptors.

期刊：Journal of medicinal chemistry发表年份：2014作者：V Blair Journigan; Christophe Mésangeau; Neha Vyas; Shainnel O Eans; Stephen J Cutler; Jay P McLaughlin; Catherine Mollereau; Christopher R McCurdy
阅读更多 →